Christopoulos, Petros
Bozorgmehr, Farastuk
Brückner, Lena
Chung, Inn
Krisam, Johannes
Schneider, Marc A.
Stenzinger, Albrecht
Eickhoff, Regina
Mueller, Daniel W.
Thomas, Michael http://orcid.org/0000-0001-9511-055X
Funding for this research was provided by:
Takeda Oncology
Universitätsklinikum Heidelberg
Article History
Received: 25 November 2020
Accepted: 8 June 2021
First Online: 28 June 2021
Declarations
:
: This clinical trial has been approved by the Ethics Committee of the Medical Faculty of the University of Heidelberg (AFmu-701/2019, February 21, 2020). Before participation in the trial, written informed consent is obtained from each subject according to the ICH guidelines on Good Clinical Practice. Additionally, the <i>Bundesinstitut für Arzneimittel und Medizinprodukte- BfArM</i> (Federal Institute for Drugs and Medical Devices, the medical regulatory body of the German Federal Ministry of Health) has approved the study (January 03, 2020).
: Not applicable, as no individual patient data are contained in this manuscript.
: The ABP trial receives funding from the pharmaceutical company Takeda. However, Takeda has not been involved in study design, data collection, management, data analysis and interpretation, or in the decision to submit this protocol for publication. PC reports research funding from AstraZeneca, Novartis, Roche, Takeda, and advisory board/lecture fees from AstraZeneca, Boehringer Ingelheim, Chugai, Novartis, Pfizer, Roche, Takeda. FB reports research funding from BMS and travel grants from BMS and MSD. AS receives advisory board honoraria from BMS, AstraZeneca, ThermoFisher, Novartis, speaker’s honoraria from BMS, Illumina, AstraZeneca, Novartis, ThermoFisher, MSD, Roche, and research funding from Chugai. MT reports advisory board honoraria from Novartis, Lilly, BMS, MSD, Roche, Celgene, Takeda, AbbVie, Boehringer, speaker’s honoraria from Lilly, MSD, Takeda, research funding from AstraZeneca, BMS, Celgene, Novartis, Roche and travel grants from BMS, MSD, Novartis, Boehringer. All other authors declare no conflicts of interest.